| Symbol | AYAUF |
|---|---|
| Name | ARTRYA LTD |
| Sector | UNDEFINED |
| Region | Oceania |
| Industry | - |
| Address | 6005 Australia WA 1257 Hay Street |
| Telephone | +61 499 100 038 |
| Fax | — |
| — | |
| Website | https://artrya.com/ |
| Incorporation | AU |
| Incorporated On | 2018 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: ASX - Australian Securities Exchange |
| CIK | — |
| Description | Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Additional info from OTC: |
No news found.